Celator Pharmaceuticals raising $5 million for cancer treatments
Celator Pharmaceuticals, a drug development company, is raising $5 million as its drug therapy for acute myeloid leukemia moves through phase 2 clinical trials. In its latest financing round, the company, which has offices in Princeton, New Jersey and Vancouver, British Columbia, has raised $2.57 million of its $5 million target through equity, options and […]